Vancomycin administration during dialysis with low-flux polysulfone membranes: traditional versus a supplemental dosage regimen.
Stamatakis
Mary K
MK
Department of Clinical Pharmacy, School of Pharmacy, West Virginia University, 1124 Health Sciences North, P.O. Box 9520, Morgantown, WV 26506-9520, USA.
Schreiber
Joy M
JM
Slain
Douglas
D
Gunel
Erdogan
E
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics / Q000493:pharmacokinetics*; D002626:Chemistry, Pharmaceutical; D004334:Drug Administration Schedule; D023381:Endpoint Determination; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006207:Half-Life; D006801:Humans; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D011108:Polymers; D006435:Renal Dialysis / Q000379:methods*; D013450:Sulfones; D014640:Vancomycin / Q000008:administration & dosage / Q000191:economics / Q000493:pharmacokinetics*
D000900:Anti-Bacterial Agents; D008567:Membranes, Artificial; D011108:Polymers; D013450:Sulfones; C017662:polysulfone P 1700; D014640:Vancomycin